Renovaro BiosciencesRENB 
$0.53-2.96%24h
-2.96%24h
Global rank27151
Market cap$29.54M
Change 7d-23.69%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.74
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences (RENB) Total Liabilities
RENB Total Liabilities in 2022: $11.80M
According to Renovaro Biosciences latest financial reports the total liabilities of RENB is $11.80M, an decrease of -1.79% to 2022. At the end of 2022 company had $12.01M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Renovaro Biosciences is responsible for during its operational activities.
Renovaro Biosciences (RENB) Total Liabilities History from 2023 to 2022
-
Value:-
RENB Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $11.80M | -1.79% |
| 2022 | $12.01M | -19.60% |
| 2021 | $14.94M | 26.31% |
| 2020 | $11.83M | 90.63% |
| 2019 | $6.21M | - |
View the Top Total Liabilies Stocks
